Khair Mufti

PhD Candidate (September 2020)
The Canadian Pharmacogenomics Network for Drug Safety
Research: Studying the Pharmacogenomics of severe adverse reactions induced by cancer therapies in pediatric patients with Acute Lymphoblastic Leukemia (ALL)
Keywords: pharmacogenomics, precision medicine, drug safety